News
Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
India Today on MSN10d
Wegovy weight-loss drug now in India: How it works and who should take itNovo Nordisk has introduced Wegovy, a once-weekly weight loss injection, in India. The drug aims to manage obesity and reduce ...
East Idaho News on MSN3d
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patientsTara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...
Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...
HealthDay on MSN10d
Rival GLP-1 Weight-Loss Drug Emerges From ChinaTUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to ...
A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...
The drug will follow a four-week cycle for dosage, starting with the smallest dose of 0.25 mg per week for four weeks, ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli Lilly began marketing its rival product Mounjaro in the world's most populous ...
Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback